Indefinite Delivery Contract 36C25818D0043

The Department of Health and Human Services Food and Drug Administration awarded an indefinite delivery contract to Molecular Epidemiology Inc. to provide microbiological analysis and whole genome sequencing services. The single award IDV has a potential value of $10 million and a period of performance through May 2027. Five firm fixed price task orders have been issued against the contract to date for specific services. These include analysis of Cyclospora cayetanensis oocysts, shrimp...

This Blanket Purchase Agreement (BPA) was awarded by the Engineer Research and Development Center, a component of the U.S. Army Corps of Engineers, to Fulgent Genetics, Inc., a for-profit company specializing in advanced genetic testing and genomic services. The $1.6 million single-award BPA, with a period of performance through February 2023, seeks to procure genomic sequencing services under the designation "SEQUENCING U433D30." Fulgent Genetics, through its subsidiaries, provides...

The Department of the Army Medical Command awarded multiple blanket purchase agreements to PreventionGenetics LLC for genetic testing services. The agreements have a potential value of $950,000 and require the contractor to provide genetic testing and variant confirmation services including whole genome sequencing and deletion/duplication analysis using next generation sequencing technology. Services are to be provided to Tripler Army Medical Center in Hawaii as detailed in the performance...

The Department of the Army Medical Command awarded multiple blanket purchase agreements to Fulgent Therapeutics LLC for genetic testing services. The agreements have a potential value of $950,000 and require the contractor to provide genetic testing and variant confirmation services using whole genome sequencing and deletion/duplication analysis next generation sequencing technology. Performance is to be provided to Tripler Army Medical Center in Hawaii through September 2025. The original...

The Department of the Army Medical Command awarded multiple blanket purchase agreements to Ambry Genetics Corporation for genetic testing services. The agreements have a potential value of $950,000 and require the contractor to provide genetic testing and variant confirmation services using whole genome sequencing and deletion/duplication analysis with next-generation sequencing technology. Performance is to be provided to Tripler Army Medical Center in Hawaii through September 7, 2025. The...

The Department of the Army Medical Command awarded multiple blanket purchase agreements to Invitae Corporation for genetic testing services. The agreements have a potential value of $950,000 and require the contractor to provide genetic testing and variant confirmation services using next generation sequencing technology. Services include whole genome sequencing and deletion/duplication analysis. Performance is to be provided to Tripler Army Medical Center in Hawaii as detailed in the...

The Department of the Army Medical Command awarded multiple blanket purchase agreements to Centogene US LLC for genetic testing services. The BPAs have a potential value of $950,000 and require services to be delivered to Tripler Army Medical Center in Hawaii by September 7, 2025. The original solicitation sought quotes for whole genome sequencing, deletion/duplication analysis, and variant confirmation to be performed using next generation sequencing technology. The services aim to provide...

Roche Diagnostics Corporation was awarded a single-award indefinite delivery contract by the Department of the Army Medical Command on August 30, 2011, with a potential value of $1,000,000. The contract provides for the delivery of a 454 GS Junior Genome Sequencer to support the agency's genomics research and analysis activities. Two delivery orders have been placed against the contract to date. The first, awarded on September 1, 2011 and valued at $17,923, scheduled delivery of the sequencing...

The Department of the Army Medical Command awarded Ezbiome Inc. a single award indefinite delivery contract with a potential value of $546,250 to provide metagenome sequencing services. No set-aside was used. The period of performance for ordering runs through September 2027. Under this contract, the Army Medical Command issued Ezbiome a $31,510 firm fixed price delivery order for 16S ribosomal RNA gene amplicon reads and sample analysis. This task order has a period of performance from...

This single-award Indefinite Delivery Contract (IDC) was awarded by the National Institutes of Health (NIH) Clinical Center to Genedx, LLC, a small business subsidiary of Opko Health, Inc. The contract has a ceiling value of $2,530,960 and a period of performance through June 30, 2026. The contract is for Genedx to provide a wide range of genetic testing services to support NIH's clinical research and patient care programs. Services include mutation analysis, exome and genome sequencing, gene...